Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Subcutaneous dosage and administration of anti-C5 antibodies for treatment of paroxysmal nocturnal hemoglobinuria (PNH)

Subcutaneous dosage and administration of anti-C5 antibodies for treatment of paroxysmal nocturnal hemoglobinuria (PNH)

US Patent 12240893 · Granted Mar 4, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Monovalent anti-properdin antibodies and antibody fragments2025
Dosage and administration of anti-C5 antibodies for treatment of atypical hemoly2025
Method and apparatus for acquiring prop information, device, and computer readab2025
Dosage and administration of anti-C5 antibodies for treatment of paroxysmal noct2025
Dosage and administration of anti-C5 antibodies for treatment of paroxysmal noct2025
Energy-saving system and method for direct air capture with precise ion control2025
Infant transport system and assembly with caster alignment2025
Spatial relation parameter selection method, apparatus, and device2025
Programmable control system and method for solid state drive2025
Sensor fusion for object detection2025
Communication method and apparatus2025
Hybrid solid state drive (SSD) architecture using MRAM and NAND for improved pow2025